英文摘要 |
The goal of precision medicine is to find potential phenotypical and genotypical differences of individuals that determine disease risk and treatment response, so as to guide personalized treatment with improved outcomes. Due to the widely use of electronic medical records and the decoding of human genome, multi-dimensional medical big data has been generated for the development of precision medicine. These big data can use artificial intelligence (machine learning) algorithms to find implicit phenotypical or genotypical structures to guide precise treatment or preventive measures. Contemporary medicine is based on randomized clinical trials, seeking the population average rather than individual best treatment results, which is in sharp contrast with the precision medicine decision-making process. However, the process of using artificial intelligence to develop precision medicine will encounter many challenges, including: (1) The process of machine learning algorithms is a black box and cannot form specific and effective medical knowledge. (2) Machine learning algorithms are based on associational inferences rather than causal inference, and (3) there is no legal framework to regulate the implementation of machine learning software into the clinical decision-making process. This article will review the current literatures on these key points and discuss the opportunities and challenges of using artificial intelligence to develop precision medicine. |